MEDIHALER-EPI Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Medihaler-epi, and when can generic versions of Medihaler-epi launch?
Medihaler-epi is a drug marketed by 3M and is included in one NDA.
The generic ingredient in MEDIHALER-EPI is epinephrine bitartrate. There are twenty-one drug master file entries for this compound. Additional details are available on the epinephrine bitartrate profile page.
Summary for MEDIHALER-EPI
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 79 |
Formulation / Manufacturing: | see details |
DailyMed Link: | MEDIHALER-EPI at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for MEDIHALER-EPI
US Patents and Regulatory Information for MEDIHALER-EPI
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3m | MEDIHALER-EPI | epinephrine bitartrate | AEROSOL, METERED;INHALATION | 010374-003 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |